To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Esophageal Cancer Awareness Association, Inc.


P.O. Box 55071 #15530
Boston, MA 02205-5071





800 Number


Email Address

[email protected]


The Esophageal Cancer Awareness Association, Inc., (ECAA) is a voluntary, non-profit rare disorder organization whose mission is to promote worldwide understanding and support for esophageal cancer patients and caregivers. There are two major types of esophageal cancer, squamous cell and adenocarcinoma of the esophagus. These two conditions make up between 12,000 and 18,000 cases per year in the United States. ECAA was formed in July 2002 and conducted its first annual meeting that same year. It provides support groups, patient networking, and advocacy for patients and families. ECAA also provides education to professionals.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.